A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures

American Journal of Gastroenterology

Volumn 100, Issue 11, 2005, Pages 2419-2425

  Ramage Jr , Jack I ^a   Rumalla, Ashwin ^a   Baron, Todd H ^a   Pochron, Nicole L ^a   Zinsmeister, Alan R ^a   Murray, Joseph A ^a   Norton, Ian D ^a   Diehl, Nancy ^a   Romero, Yvonne ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID; PLACEBO; PROTON PUMP;

ADULT; ARTICLE; BALLOON DILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPHAGIA; ENDOSCOPIC THERAPY; ESOPHAGITIS; ESOPHAGUS DILATATION; ESOPHAGUS STRICTURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; STOMACH ACID SECRETION; STOMACH DISEASE; STOMACH FUNDOPLICATION; AGED; CLASSIFICATION; COMPARATIVE STUDY; DRUG ANTAGONISM; ESOPHAGOSCOPY; ESOPHAGUS STENOSIS; FOLLOW UP; GASTROESOPHAGEAL REFLUX; INTRALESIONAL DRUG ADMINISTRATION; METHODOLOGY; RECURRENT DISEASE; RETREATMENT;

AGED; BALLOON DILATATION; DEGLUTITION DISORDERS; DOUBLE-BLIND METHOD; ESOPHAGEAL STENOSIS; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; PLACEBOS; PROSPECTIVE STUDIES; PROTON PUMPS; RECURRENCE; RETREATMENT; TRIAMCINOLONE;

EID: 33644643616     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00331.x     Document Type: Article

References (26)

1. Spechler SJ. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999 117 : 233 54 ( see comment).
2. Ben Rejeb M Bouche O Zeitoun P. Study of 47 consecutive patients with peptic esophageal stricture compared with 3880 cases of reflux esophagitis. Dig Dis Sci 1992 37 : 733 6.
3. Patterson DJ Graham DY Smith JL, et al. Natural history of benign esophageal stricture treated by dilatation. Gastroenterology 1983 85 : 346 50.
4. Ogilvie AL Ferguson R Atkinson M. Outlook with conservative treatment of peptic oesophageal stricture. Gut 1980 21 : 23 5.
5. Hands LJ Papavramidis S Bishop H, et al. The natural history of peptic oesophageal strictures treated by dilatation and antireflux therapy alone. Ann R Coll Surg Engl 1989 71 : 306 9 (discussion 9-10).
6. Smith PM Kerr GD Cockel R, et al. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology 1994 107 : 1312 8 ( see comment).
7. Berenson GA Wyllie R Caulfield M, et al. Intralesional steroids in the treatment of refractory esophageal strictures. J Pediatr Gastroenterol Nut 1994 18 : 250 52.
8. Holder TM Ashcraft KW Leape L. The treatment of patients with esophageal strictures by local steroid injections. J Pediatr Surg 1969 4 : 646 53.
9. Kirsch M Blue M Desai RK, et al. Intralesional steroid injections for peptic esophageal strictures. Gastrointest Endosc 1991 37 : 180 82.
10. Kochhar R Ray JD Sriram PV, et al. Intralesional steroids augment the effects of endoscopic dilation in corrosive esophageal strictures. Gastrointest Endosc 1999 49 : 509 13.
11. Lee M Kubik CM Polhamus CD, et al. Preliminary experience with endoscopic intralesional steroid injection therapy for refractory upper gastrointestinal strictures. Gastrointest Endosc 1995 41 : 598 601.
12. Zein NN Greseth JM Perrault J. Endoscopic intralesional steroid injections in the management of refractory esophageal strictures. Gastrointest Endosc 1995 41 : 596 8.
13. Dunne D Rupp T Rex D, et al. Five year follow-up of prospective randomized trial of savory dilation with or without intralesional steroids for benign gastroesophageal reflux strictures. Gastroenterology 1999 116 : A152.
14. Marks RD Richter JE Rizzo J, et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994 106 : 907 15 ( see comment).
15. Starlinger M Appel WH Schemper M, et al. Long-term treatment of peptic esophageal stenosis with dilatation and cimetidine: Factors influencing clinical result. Eur Surg Res 1985 17 : 207 14.
16. Farup PG Modalsli B Tholfsen JK. Long-term treatment with 300 mg ranitidine once daily after dilatation of peptic oesophageal strictures. Scand J Gastroenterol 1992 27 : 594 8.
17. Locke GR Talley NJ Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994 69 : 539 47.
18. Moher D Schulz K Altman D. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001 285 : 1987 91.
19. Agnew SR Pandya SP Reynolds RP, et al. Predictors for frequent esophageal dilations of benign peptic strictures. Dig Dis Sci 1996 41 : 931 6.
20. Cox JG Winter RK Maslin SC, et al. Balloon or bougie for dilatation of benign oesophageal stricture? An interim report of a randomised controlled trial. Gut 1988 29 : 1741 7.
21. Kochhar R Makharia GK. Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures. Gastrointest Endosc 2002 56 : 829 34.
22. Rayner TE Cowin AJ Robertson JG, et al. Mitogenic whey extract stimulates wound repair activity in vitro and promotes healing of rat incisional wounds. Am J Physiol Regul Integr Comp Physiol 2000 278 : R1651 60.
23. Rudd P Byyny RL Zachary V, et al. Pill count measures of compliance in a drug trial: Variability and suitability. Am J Hypertens 1988 1 : 309 12.
24. Friedman RH Kazis LE Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996 9 : 285 92.
25. Pullar T Kumar S Tindall H, et al. Time to stop counting the tablets? Clin Pharmacol Ther 1989 46 : 163 8.
26. Choo PW Rand CS Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999 37 : 846 57.